| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/27/2000 | CA2333471A1 Human scad-related molecules, scrm-1 and scrm-2 |
| 01/27/2000 | CA2333467A1 Human presenilin-associated protein |
| 01/27/2000 | CA2332722A1 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 01/27/2000 | CA2331340A1 Glucoamylase variants |
| 01/27/2000 | CA2327921A1 Compositions and methods for fumonisin detoxification |
| 01/27/2000 | CA2303062A1 Human aspartic proteases |
| 01/26/2000 | EP0974670A2 Process for producing optically active N-substituted azetidine-2-carboxylic acid compound |
| 01/26/2000 | EP0974669A1 PROCESS FOR PREPARING $g(a)-HYDROXY ACIDS USING MICROORGANISM AND NOVEL MICROORGANISM |
| 01/26/2000 | EP0974668A1 Use of adenoviral E4 reading frames to improve expression of a gene of interest |
| 01/26/2000 | EP0974666A1 Methods for transferring gene into chromosome |
| 01/26/2000 | EP0974663A1 Lipoprotein associated phospholipase A2, inhibitors thereof and use of same in diagnosis and therapy |
| 01/26/2000 | EP0974662A1 Process for producing dihydroxyacetone 3-phosphate |
| 01/26/2000 | EP0974661A1 Geranyl diphosphate synthase genes |
| 01/26/2000 | EP0974659A2 Viral nucleotide sequences |
| 01/26/2000 | EP0974656A1 Dna gyrase inhibitor protein |
| 01/26/2000 | EP0974654A2 Method for secretory production of human growth hormone |
| 01/26/2000 | EP0974647A1 Process for producing target substances by fermentation |
| 01/26/2000 | EP0974645A1 Procedure to prepare, by the use of microwaves, sterile liquid or solid culture media, for the recognition and identification of recombinant microorganisms |
| 01/26/2000 | EP0974644A1 Method for producing freeze resitant yeast |
| 01/26/2000 | EP0974268A1 Bifidobacterium-fermented milk and process for producing the same |
| 01/26/2000 | EP0974111A1 Apparatus and method for automated protein design |
| 01/26/2000 | EP0974058A2 20 human secreted proteins |
| 01/26/2000 | EP0974051A1 A method to identify plant proteins that function in g-protein coupled systems and compositions therefor |
| 01/26/2000 | EP0973944A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 01/26/2000 | EP0973920A1 An oleosin 5' regulatory region for the modification of plant seed lipid composition |
| 01/26/2000 | EP0973918A1 Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal rna encoding domain, particularly with kluyveromyces |
| 01/26/2000 | EP0973917A1 Agrobacterium mediated transformation of moulds, in particular those belonging to the genus aspergillus |
| 01/26/2000 | EP0973915A1 Recombinant microorganisms capable of fermenting cellobiose |
| 01/26/2000 | EP0973909A2 Process for extracting and purifying recombinant, non-lipidised osp-protein |
| 01/26/2000 | EP0973903A2 Protein for inhibiting apoptosis |
| 01/26/2000 | EP0973897A1 Human tumor-associated membrane protein |
| 01/26/2000 | EP0973894A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 01/26/2000 | EP0973892A2 28 human secreted proteins |
| 01/26/2000 | EP0973891A1 Human chemokine receptor-like chemokine |
| 01/26/2000 | EP0973889A1 Human calcium channels alfa1 subunits and related probes, cell lines and methods |
| 01/26/2000 | EP0973888A1 Dendritic cell-derived growth factor |
| 01/26/2000 | EP0973887A1 Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof |
| 01/26/2000 | EP0973882A1 DEVELOPMENT OF HIGH-ETHANOL RESISTANT $i(ESCHERICHIA COLI) |
| 01/26/2000 | EP0973876A1 DNA ENCODING $i(PNEUMOCYSTIS CARINII) PROTEASE |
| 01/26/2000 | EP0973874A2 Enzyme assay for mutant firefly luciferase |
| 01/26/2000 | EP0973866A1 Adenovirus e1-complementing cell lines |
| 01/26/2000 | EP0973865A2 Attenuated, invasive vaccines against fish pathogens |
| 01/26/2000 | EP0973864A1 Novel microorganisms |
| 01/26/2000 | EP0973803A1 Peptides useful for reducing symptoms of toxic shock syndrome |
| 01/26/2000 | EP0973794A1 Netrin receptors |
| 01/26/2000 | EP0973760A1 Kodaistatins a, b, c and d, a process for their production and their use |
| 01/26/2000 | EP0973399A1 Improved method for preparing flour doughs and products made from such doughs using glycerol oxidase |
| 01/26/2000 | EP0973394A1 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO $i(HELICOBACTER PYLORI) AND VACCINE COMPOSITIONS THEREOF |
| 01/26/2000 | EP0670677B1 Potentiator of Bacillus pesticidal activity |
| 01/26/2000 | EP0643766B1 Improved mixture of nutrients for the bioremediation of polluted soils and waters |
| 01/26/2000 | CN1242801A Photosynthesis culture apparatus and group of photosynthesis culture apparatuses |
| 01/26/2000 | CN1048754C Process for producing long-chain alpha omega dicarboxylic acid by synchronous fermentation of microbe |
| 01/26/2000 | CN1048731C Polynucleotide of drug binding protein as coded CSAID |
| 01/25/2000 | US6018103 Chimeric plant genes possessing independent regulatory sequences |
| 01/25/2000 | US6018030 Recombinant proteins that contain at least 50 percent of amino acids of naturally occuring repeating sequences; genetic engineering of structural components of prosthetic devices and synthetic fibers |
| 01/25/2000 | US6018028 A poylpeptide; diagnosis and therapy for alzheimer's disease, cachexia due to cancer, aqcuired immune deficiency syndrome, sepsis and trauma |
| 01/25/2000 | US6018025 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd528 as a target |
| 01/25/2000 | US6017899 Non-reducing saccharide-forming enzyme, its preparation and uses |
| 01/25/2000 | US6017870 From fermentation of trichoderma |
| 01/25/2000 | US6017762 An ascomycetes fungus strain transformed with a cassette for expressing an aspartic protease precursor; production of cooked cheeses |
| 01/25/2000 | US6017749 A biological culture capable of producing protease, xylanse and cellulase |
| 01/25/2000 | US6017748 Cloning host organisms |
| 01/25/2000 | US6017736 High yield process by base exchange reaction between pyrimidine nucleoside and purine base in phosphate ion-containing aqueous solution in presence of purine and pyrimidine nucleoside phosphorylases |
| 01/25/2000 | US6017735 A fusion polypeptide having a herpes virus virion protein and a second protein selected from cell cycle control, suicide protein, antigenic sequences, immunomodulating or therapeutic protein; antiproliferative/anticarcinogenic agents |
| 01/25/2000 | US6017731 Nucleotide sequences encoding a signal sequence, a propeptide leader sequence, a preferred processing site cleaved in situ by a yeast proteolytic enzyme; expressing mammalian proteins and their secretion in a biologically active mature form |
| 01/25/2000 | US6017729 Receptor activator of NF-κB |
| 01/25/2000 | US6017728 ribH |
| 01/25/2000 | US6017726 Efficient process for producing 7-aminodeacetyl-cephalosoporanic acid by culturing penicillium chrysogenum with adipic acid, salt or ester to produce adipoyl-6-aminopenicillanic acid, then enzymatically altering molecule |
| 01/25/2000 | US6017705 Nucleic acid molecules that codes for tumor rejection antigens; diagnosis and screening for possible presence of lymphoma, or head and neck squamous cell carcinoma, skin and mammary carcinomas |
| 01/25/2000 | US6017538 Plasmodium falciparum antigens inducing protective antibodies |
| 01/25/2000 | US6017534 Development of transgenic plants which express broad-spectrum insecticidal activity against a variety of flies, moths and beetles; chimeric crystal delta-endotoxins having improved insecticidal properties and broad-range specificities |
| 01/25/2000 | CA2145859C Bacillus thuringiensis cryet4 and cryet5 toxin genes and proteins toxic to lepidopteran insects |
| 01/25/2000 | CA2027629C Glycopeptide antibiotics |
| 01/20/2000 | WO2000003244A2 Immortalized human keratinocyte cell line |
| 01/20/2000 | WO2000003036A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 01/20/2000 | WO2000003029A2 Chimaeric adenoviruses |
| 01/20/2000 | WO2000003023A1 Usurpin, a mammalian ded-caspase homologue that precludes caspase-8 recruitment and activation by the cd-95 (fas, apo-1) receptor complex |
| 01/20/2000 | WO2000003021A2 Metabolically engineered microbial cell comprising a modified redox activity |
| 01/20/2000 | WO2000003016A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 01/20/2000 | WO2000003015A2 Human transport protein homologs |
| 01/20/2000 | WO2000003010A2 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon |
| 01/20/2000 | WO2000003008A2 Recombinant haploid or diploid yarrowia lipolytica cells for the functional heterologous expression of cytochrome p450 systems |
| 01/20/2000 | WO2000003000A2 Serum-free medium for culturing animal cells |
| 01/20/2000 | WO2000002996A2 Recombinant constructs and systems for secretion of proteins via type iii secretion systems |
| 01/20/2000 | WO2000002919A1 Growth hormone secretagogue related receptors and nucleic acids |
| 01/20/2000 | WO2000002918A1 Mouse growth hormone secretagogue receptor |
| 01/20/2000 | WO2000002914A1 Modified proteins |
| 01/20/2000 | WO2000002912A2 Disintegrin homologs |
| 01/20/2000 | WO2000002911A2 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/20/2000 | WO2000002897A2 Delta cleavage products and methods based thereon |
| 01/20/2000 | WO2000002839A1 Cytokine production and tyrosine kinase inhibitors |
| 01/20/2000 | WO1999060138A3 Regulated expression of pkc and/or srb1/psa1 in yeast |
| 01/20/2000 | WO1999060117A3 Prax-1 polypeptide |
| 01/20/2000 | WO1999058690A3 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch |
| 01/20/2000 | WO1999058559A3 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 01/20/2000 | WO1999049037A3 Protein phosphatase-related molecules |
| 01/20/2000 | WO1999048916A3 Hypoxia-inducible human genes, proteins, and uses thereof |
| 01/20/2000 | WO1999047674A3 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/20/2000 | WO1999038964A3 Promoter regions of the mouse and human telomerase rna component genes |
| 01/20/2000 | DE19932811A1 Recombinant haploid or diploid Yarrowia lipolytica for functional heterologous expression of cytochrome P450 systems |